| 21 |
Gefitinib in Non-Small Cell Lung Cancer: A Prospective Study at South Egypt Cancer Institute |
Department of Medical Oncology |
2025 |
| 22 |
Impact of body mass index at diagnosis on outcomes of pediatric stage III and IV mature B-cell non-hodgkin lymphoma at South Egypt Cancer Institute: A prospective cohort study |
|
2025 |
| 23 |
Klotho and LRP6 as Emerging Biomarkers in Gastric Adenocarcinoma: Expression Patterns and Clinical Relevance |
Department of Medical Oncology |
2025 |
| 24 |
Long noncoding RNA antisense noncoding RNA in the INK4 locus as a diagnostic and prognostic biomarker in acute myeloid leukemia |
Department of Clinical Pathology |
2025 |
| 25 |
Mizolastine-loaded spanlastics for treatment of atopic dermatitis: immunomodulatory approach for management of inflammation |
Department of Clinical Pathology |
2025 |
| 26 |
Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters |
Department of Medical Oncology |
2025 |
| 27 |
Predictive and Prognostic Significance of Serum Neuron Specific Enolase in Patients with Metastatic Non-Small Cell Lung Cancer Receiving Gefitinib: A Prospective Study from South Egypt Cancer Institute |
Department of Medical Oncology |
2025 |
| 28 |
Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients |
Department of Medical Oncology |
2025 |
| 29 |
Primary Cytoreductive Surgery Versus Neoadjuvant Chemotherapy Followed by Surgery in Patients with Advanced Primary Epithelial Ovarian Cancer in Low Resources Setting: A Randomized Clinical Trial |
|
2025 |
| 30 |
Prognostic role of p16 gene methylation in diffuse large B-cell lymphoma |
Department of Clinical Pathology |
2025 |
